Suppr超能文献

基因表达谱分析揭示了用于识别外周 T 细胞肿瘤中间变大细胞淋巴瘤的分子分类器。

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.

机构信息

Department of Pathology, Center for Experimental Research and Medical Studies, Laboratory of Functional Genomics, University of Torino, Torino, Italy.

出版信息

J Clin Oncol. 2010 Mar 20;28(9):1583-90. doi: 10.1200/JCO.2008.20.9759. Epub 2010 Feb 16.

Abstract

PURPOSE

To unravel the regulatory network underlying nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) -mediated lymphomagenesis of anaplastic large-cell lymphoma (ALCL) and to discover diagnostic genomic classifiers for the recognition of patients with ALK-positive and ALK-negative ALCL among T-cell non-Hodgkin's lymphoma (T-NHL).

PATIENTS AND METHODS

The transcriptome of NPM-ALK-positive ALCL cell lines was characterized by silencing the expression of ALK or STAT3, a major effector of ALK oncogenic activity. Gene expression profiling (GEP) was performed in a series of systemic primary T-NHL (n = 70), including a set of ALK-positive and ALK-negative ALCL (n = 36). Genomic classifiers for ALK-positive and ALK-negative ALCL were generated by prediction analyses and validated by quantitative reverse-transcriptase polymerase chain reaction and/or immunohistochemistry.

RESULTS

In ALCL cell lines, two thirds of ALK-regulated genes were concordantly dependent on STAT3 expression. GEP of systemic primary T-NHL significantly clustered ALK-positive ALCL samples in a separate subgroup, underscoring the relevance of in vitro ALK/STAT3 signatures. A set of genomic classifiers for ALK-positive ALCL and for ALCL were identified by prediction analyses. These gene clusters were instrumental for the distinction of ALK-negative ALCL from peripheral T-cell lymphomas not otherwise specified (PTCLs-NOS) and angioimmunoblastic lymphomas.

CONCLUSION

We proved that experimentally controlled GEP in ALCL cell lines represents a powerful tool to identify meaningful signaling networks for the recognition of systemic primary T-NHL. The identification of a molecular signature specific for ALCL suggests that these T-NHLs may represent a unique entity discernible from other PTCLs, and that a restricted number of genes can be instrumental for clinical stratification and, possibly, therapy of T-NHL.

摘要

目的

阐明核仁磷酸蛋白-间变性淋巴瘤激酶(NPM-ALK)介导的间变大细胞淋巴瘤(ALCL)淋巴瘤发生的调控网络,并发现用于识别 T 细胞非霍奇金淋巴瘤(T-NHL)中 ALK 阳性和 ALK 阴性 ALCL 患者的诊断基因组分类器。

患者和方法

通过沉默 ALK 或 STAT3(ALK 致癌活性的主要效应物)的表达,对 NPM-ALK 阳性 ALCL 细胞系的转录组进行了表征。对一系列系统性原发性 T-NHL(n=70)进行了基因表达谱分析(GEP),其中包括一组 ALK 阳性和 ALK 阴性 ALCL(n=36)。通过预测分析生成了用于 ALK 阳性和 ALK 阴性 ALCL 的基因组分类器,并通过定量逆转录聚合酶链反应和/或免疫组织化学进行了验证。

结果

在 ALCL 细胞系中,三分之二的 ALK 调节基因与 STAT3 表达一致。系统性原发性 T-NHL 的 GEP 显著将 ALK 阳性 ALCL 样本聚类到一个单独的亚组中,强调了体外 ALK/STAT3 特征的相关性。通过预测分析确定了一组用于 ALK 阳性 ALCL 和 ALCL 的基因组分类器。这些基因簇对于将 ALK 阴性 ALCL 与非特指外周 T 细胞淋巴瘤(PTCL-NOS)和血管免疫母细胞性淋巴瘤区分开来非常重要。

结论

我们证明了在 ALCL 细胞系中经过实验控制的 GEP 是识别用于识别系统性原发性 T-NHL 的有意义的信号网络的有力工具。ALK 特异性分子特征的鉴定表明,这些 T-NHL 可能代表一种独特的实体,可与其他 PTCL 区分开来,并且少数基因可能对临床分层和可能的 T-NHL 治疗具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验